GB06 Phase III Trial for Pediatric Growth Hormone Deficiency

Clinical trial NCT07553351 · RECRUITING

Trial details

NCT number: NCT07553351
Sponsor: Kexing Biopharm Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Growth Hormone Deficiency (GHD)Growth Hormone Deficiency in Children Growth Hormone Deficiency, Pediatric

Start date: 2026-06-06
Primary completion: 2028-07-25
Enrollment: 192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.